logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: drug-use
Load new posts () and activity
Like Reblog Comment
text 2021-11-27 15:50
What Treatments Prove Helpful To Come Out Of Drug Addiction?

Addiction needs proper treatment. Depending on the condition and needs, experts may suggest prescriptions. The treatments have to be monitored by experts. It is important to help the patient maintain a healthy mental and physical condition.

 

Recovery is not impossible if you have approached the best drug addiction Lexington KY team. 

 

  • The treatment choice will depend on the condition of the patient 
  • Medicine prescriptions have to be implemented for the patients as a part of the treatment
  • Recreational exercises also prove a lot helpful for the patients

 

  • Detoxification

 

Detoxification may not be the same for everyone. If you have been dependent on the drugs for a longer time, then detoxification becomes more difficult. The drug ingredients have to be cleaned from the bloodstream before any treatment.

 

If the drug is present in the blood, then detoxification becomes painful. In most cases, withdrawal symptoms are never mild. Drug addiction rehab facilities Lexington KY team will take extra care of the patient during the detoxification stage.

 

  • Cognitive therapy

 

In most cases implementing CBT proves a lot helpful. The implementation stage may differ for each patient. All types of drugs and effects may not be the same. Even if you have been addicted to prescription medicines, still CBT may vary.

 

A professional therapist will try and identify the negative behaviour pattern in the patient before treating. This is important to identify the factors that might have led to addiction. Drug addiction Lexington KY team will begin with the treatment only if they have identified the real cause of addiction.

 

  • Emotional therapy

 

Emotional therapy will prove helpful in identifying negative thoughts. In most cases, denial is one of the main culprits. People who are denied by their loved ones will often fall prey to addiction.

 

It is important to make these individuals feel loved and cared for before the treatment begins. The expert will have to implement positive thoughts in these patients.

 

  • Contingency management treatment

 

This is a very effective rehab treatment. It is useful for curing any type of addiction. The treatment mainly focuses on triggering positive behaviour patterns in the patient. Combating relapses is also important.

 

You may have to approach the best drug addiction rehab facilities Lexington KY team for implementing CM treatment. The therapy is rewarding only if it has been offered by the professional therapist.

 

  • Facilitation therapy

 

The moment expert will implement facilitation therapy he will focus on the physical, mental and spiritual well being of the patient. No therapy can work unless it has been accepted by the patient and the family members.

 

Drug abuse can leave a very negative impact on the mind. It makes a person mentally unstable. Maintaining the right mental stability is important. To a certain extent, medicines are also important. But medicines must be implemented only by a professional team.

 

Without proper guidance, it is not possible to come out of the addiction safely. Most people fail because they give up hope. This is where experts prove helpful. They keep patients motivated to keep improving their physical and mental conditions.

 

In case you have a loved one struggling with addiction, then you should help them find the best therapy.

Like Reblog Comment
text 2021-10-26 09:11
Drug Eluting Stent Market Growth Report by 2024 With Key Players : AlviMedica & Arterius

The Drug Eluting Stent Market is projected to register a higher CAGR during the forecast period. The drug eluting stent market is highly driven by change in consumers’ lifestyles, heavy consumption of junk food, and prevalence of atherosclerosis in geriatric population. Adoption of minimally invasive techniques may augment the market demand for drug eluting stents.

 

Get Sample Inquary @ https://bit.ly/3nvHeBu

 

 

Increase in geriatric population and shift from angioplasty to DES are likely to propel the market growth during the forecast period. Market challenges such as declining prices and side effects pertaining to the use of drug eluting stents might impede the market growth. Based on polymer coating, the drug eluting stents market comprises non-biodegradable polymer-based and biodegradable polymer based. Based on polymer free coatings, the drug eluting stent industry includes nanoporous surface, slotted tubular surface, micro porous surface and microstructures surface.

 

By application, the market segmentation includes coronary artery disease and peripheral artery disease. Geographical segmentation for drug eluting stent market includes North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. North America is a dominant market with greater revenue share. The market is driven by stringent norms and regulations along with favorable reimbursement coverage. Rise in incidences of artery diseases is expected to favor the market growth in the forecast period.

 

Asia-Pacific’s market is anticipated to register a higher market growth in the forecast period owing to rise in patients’ awareness pertaining to commercial availability of products, government funding and constant R&D. Improvements in healthcare infrastructure and increase in healthcare spending is likely to propel the market growth APAC sector.

 

The key players in the drug eluting stents industry include Abbott Laboratories, AlviMedica, Arterius, Biotronik SE Co & KG, Biosensors International Group Ltd, Boston Scientific Corporation, Cook Medical Inc, Elixir Medical Inc. Other vendors include Kyoto Medical Planning Co Ltd, Lepu Medical Technology Co Ltd, Micell Technologies Inc, Medtronic Plc, Eurocor GmbH, Opto Circuits, OrbusNeich Medical Company Ltd, QualiMed, Sino Medical Sciences Technology Inc, Sino Medical Sciences Technology Inc, and Stentys SA.

 

View Full Report with TOC @ https://bit.ly/3EmVtzr

 

Market Segment:

Drug Eluting Stent Market, by Product, 2013 - 2024 (USD Million)
    • Polymer-based Coatings
    • Polymer-free Coatings

 

Drug Eluting Stent Market, by Application, 2013 - 2024 (USD Million)
    • Coronary Artery Disease
    • Peripheral Artery Disease

 

Get in touch                                                          

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

 

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email:ryan@millioninsights.com

Source: bit.ly/3nvHeBu
Like Reblog Comment
text 2021-09-07 10:51
Drug Screening Market : Indicates Impressive Growth Rate In Chromatography Industry

According to the new market research report ” Drug Screening Market by Product (Consumables, Urine testing devices, Analytical, Breathalyzer, Chromatography) & Services, Sample Type (Urine, Breath), End User (Workplace, Laboratories, Criminal Justice, Hospitals) – Global Forecast to 2025″, published by MarketsandMarkets™ , global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3%.

Major Growth Drivers:

Growth in this market is attributed to the rising drug & alcohol consumption, the enforcement of stringent laws mandating drug and alcohol testing, government funding in major markets, and regulatory approvals and product and service launches.

Expected Revenue Growth:

[192 Pages Report] The global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3%.

COVID-19 impact on the drug screening market

COVID-19 has resulted in significant disruptions to businesses and economic activities globally and is expected to have a short-term negative impact on the drug screening market due to limited or non-availability of medical facilities/treatment centers, harm reduction service providers, and the fear of infection transmission. To reduce the strain on the healthcare system and decrease disease transmission, various governments worldwide provided guidelines to postpone or delay non-essential medical and surgical procedures.

Browse in-depth TOC on “Drug Screening Market”192 – Tables35 – Figures192 – Pages

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773

The rapid testing devices segment will witness the highest growth during the forecast period.

Based on product, the drug screening market is segmented into analytical instruments, rapid testing devices, and consumables. Rapid testing devices market is further subsegmented into urine testing devices and oral fluid testing devices. The urine testing devices segment is expected to account for the largest market share in 2019. However, the oral fluid testing devices segment is projected to register highest CAGR during the forecast period. The high growth in this segment is attributed to the benefits it offers such as shorter detection window, non-invasive nature, and low risk of sample tampering.

North America was the largest regional market for drug screening market in 2019.

The drug screening market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America was the largest regional segment of the overall market, followed by Europe. The dominance of the North American market is attributed to factors such as rising consumption of illicit drugs, availability of government funding to curb drug abuse, and the presence of laws supporting drug screening, and growing burden of accidents due to unsafe levels of alcohol consumption.

Request for sample pages :  https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773

Key Market Players

The prominent players operating in this market include LabCorp (US), Quest Diagnostics (US), Alere (US), OraSure (US), Alfa Scientific Designs (US), Thermo Fisher Scientific (US), Drägerwerk (Germany), LifeLoc (US), MPD Inc. (US), Omega Laboratories (US), Premier Biotech (US), Psychemedics (US), Roche (Switzerland), Shimadzu (Japan), and Siemens Healthineers (Germany).

More posts
Your Dashboard view:
Need help?